Quant Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund scheme from Quant Money Managers Limited. The fund was launched on 18 July 2023 and is managed by Ayusha Kumbhat, Sameer Kate, Sanjeev Sharma, Yug Tibrewal, Varun Pattani, Ankit A. Pande, and Sandeep Tandon. As of 15 October 2026, the fund has an AUM of ₹424.53 Cr and its latest NAV is ₹17.33. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹1,000 and lumpsum investment starting from ₹5,000.
The fund primarily invests in Healthcare, Consumer Defensive, and Technology and its top holdings include Future on Glenmark Pharmaceuticals Ltd, GlaxoSmithKline Pharmaceuticals Ltd, Divi's Laboratories Ltd., Future on Divi's Laboratories Ltd, and Zydus Lifesciences Ltd. The fund has delivered 12.7% returns over the last 1 year, 17.5% annualised returns over 3 years, and 18.6% annualised returns since inception.
Quant Healthcare Fund Regular Growth may be suitable for investors looking for Sector - Healthcare and who are comfortable with Very High Risk risk.






